Long-term effects of childhood solid tumors and their treatments in survivors

Constitution d'Une Cohorte Nationale rétrospective de Survivants d'un Cancer Solide de l'Enfant diagnostiqué Avant 2000

Observational Institut National de la Santé Et de la Recherche Médicale, France · NCT01620372

This study looks at the long-term health and quality of life of childhood cancer survivors treated for solid tumors in France to see how their past treatments affect them now.

Quick facts

Study typeObservational
Enrollment18000 (estimated)
AgesN/A to 18 Years
SexAll
SponsorInstitut National de la Santé Et de la Recherche Médicale, France Government
Drugs / interventionschemotherapy, radiation
Locations36 sites (Amiens and 35 other locations)
Trial IDNCT01620372 on ClinicalTrials.gov

What this trial studies

The French Childhood Cancer Survivor Study (FCCSS) is a large-scale observational study that focuses on children treated for solid tumors in France before the year 2000. It aims to improve understanding of the long-term health and social outcomes of these survivors, including the risk of second malignancies and other health issues related to cancer treatments. The study will follow a cohort of survivors for up to 20 years, utilizing medical records, national registries, and self-questionnaires to gather comprehensive data on their health and quality of life. By identifying high-risk patients and comparing their mortality rates with the general population, the FCCSS seeks to inform better follow-up care and preventive measures.

Who should consider this trial

Good fit: Ideal candidates for this study are individuals who were diagnosed with any type of solid childhood cancer in France before the age of 19 between 1942 and 1999.

Not a fit: Patients diagnosed with leukemia will not benefit from this study as they are excluded from participation.

Why it matters

Potential benefit: If successful, this study could lead to improved long-term care and monitoring strategies for childhood cancer survivors, enhancing their quality of life.

How similar studies have performed: Other studies have shown success in understanding long-term effects of childhood cancer treatments, making this approach both relevant and necessary.

Eligibility criteria

Show full inclusion / exclusion criteria
Inclusion Criteria:

* All types of solid childhood cancer in France
* Age at diagnosis: Below age 19
* Period of diagnosis: between 1st January 1942 and 31st December 1999
* Complete identification (first name, last name, date of birth and place of birth)

Exclusion Criteria:

* Leukaemia cases

Where this trial is running

Amiens and 35 other locations

Study contacts

How to participate

  1. Review the eligibility criteria above with your treating physician.
  2. Visit the official trial page on ClinicalTrials.gov for the most current contact information and recruitment status.
  3. Contact the listed study coordinator or principal investigator to request pre-screening. Pre-screening is free and never obligates you to enroll.
Conditions Childhood Solid Tumor
Last reviewed 2026-06-13 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.